Evidence map›Paper›PMID 36713563›Full record

ArticleFrontiers in oncology2022

Clinical outcomes of salvage radiotherapy in patients with supraclavicular lymph node metastases after esophagectomy.

Zhang Ping, Zhen Chanjun, Bai Wenwen, Chen Mingyue, Su Quanbing, Wang Yajing, Zhou Zhiguo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhang PingDepartment of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zhen ChanjunDepartment of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Bai WenwenDepartment of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Chen MingyueDepartment of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Su QuanbingDepartment of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Wang YajingDepartment of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zhou ZhiguoDepartment of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the clinical outcomes of salvage radiotherapy in patients with supraclavicular lymph node (SCLN) metastases after esophagectomy. Methods: After initial esophagectomy (R0 resection), clinical outcomes in patients with esophageal squamous cell carcinoma with SCLN metastases during follow-up were retrospectively analyzed. Results: A total of 114 patients were split into two groups: the salvage radiotherapy (SR) (n=89) and the control (NSR) (without salvage radiotherapy, n=25). The overall survival rates of 1 year, 3 years and 5 years were 81.6%, 31.4% and 8.6%, accordingly. The 1-year and 3-year survival after SCLN metastases (SASM) rates were 40.2% and 14.5%, respectively; the median SASM time was 10 months. In the SR group, the SASM rates of 1-year and 3-year were 48.1% and 18.9%, compared to 12.0% and 0% in the NSR group ( Conclusion: It is possible that

Indexed as

esophageal canceresophagectomysalvage radiotherapysquamous cell carcinomasupraclavicular lymph node metastases

Identifiers

PMID36713563
PMCPMC9874849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.